This approach enables an ongoing dialogue between the regulatory body and drug developers. Expediting the review process ...

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...

Topline results from Phase 2 portion of the investigator-sponsored study of FG-3246, a first-in-class antibody-drug conjugate (ADC) targeting CD46, in combination with enzalutamide in patients with me ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Among physicians in Washington state, high prescribers of opioids were 2.9 times more likely to be high prescribers of ...

The report also spotlights the urgency of vaccines for pathogens such as group A Streptococcus and Klebsiella pneumoniae, which are increasingly resistant to antimicrobials.

Native Vote 2024. While former President Donald Trump has disavowed the Heritage Foundation’s  Project 2025, his fingerprints ...

Kenya has recorded nearly four million cases of Malaria this year, latest data from the Ministry of Health shows.

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

MANILA, Philippines — The Department of Social Welfare and Development (DSWD ... medicines” from any of 171 branches of Mercury Drug nationwide starting Nov. 4. In a statement, DSWD ...

MANILA, Philippines (AP) — The cockiness, expletives and threats unleashed by former President Rodrigo Duterte in a Senate inquiry brought back the nightmare of the bloody “war on drugs” for ...